Title List مقالات لاتين Can we improve the record efficiency of CdS/CdTe solar cells? Cancer risk in endoscopically unresectable colon polyps

بر اساس عنوان

1

Can we improve the record efficiency of CdS/CdTe solar cells?

2

Can we improve the reliability of the Constant-Murley score?

3

Can we improve the spatial predictions of seabed sediments? A case study of spatial interpolation of mud content across the southwest Australian margin

4

Can we improve trauma mortality in a state with a voluntary trauma system

5

Can we improve upon approval voting?

6

Can We Improve Upon Human Performance in the Electrophysiology Laboratory?

7

Can we increase adherence to treatment recommendations of the consultation psychiatrist working in a general hospital? A systematic review

8

Can we influence health status and semen quality of breeding stallions by feeding a prebiotic feed additive during one breeding season?

9

Can we integrate bioinformatics data on the Internet?

10

Can we interpret the evolution of coastal land use conflicts? Using Artificial Neural Networks to model the effects of alternative development policies

11

Can we justify historical control groups when using animal models?

12

Can We Learn From History and Unite as Emergency Physicians?

13

Can We Learn from the Past? A History of the Kennedy Center Alliance for Arts Education Part 1: Defining the Agenda

14

Can We Learn from the Past? A History of the Kennedy Center Alliance for Arts Education Part 1: Defining the Agenda

15

Can We Learn from the Past? A History of the Kennedy Center Alliance for Arts Education Part 2: Controlling the Agenda

16

Can We Learn from the Past? A History of the Kennedy Center Alliance for Arts Education Part 2: Controlling the Agenda

17

Can we learn more from the data underlying the statistical α–β model with respect to the dynamical behavior of avalanches?

18

Can We Leave Cognition to Cognitive Psychologists? Comments on an Article by George Loewenstein

19

Can we live on the brane in Schwarzschild–anti de Sitter black hole?

20

Can we maintain turf to customers’ satisfaction with less water?

21

CAN WE MANAGE ALLIGATOR WEED BETTER IN AUSTRALIA? LESSONS FROM HERBICIDE TRIALS

22

Can we manage ecosystems in a sustainable way?

23

Can we map swelling clays with remote sensing?

24

Can we measure in semi-inclusive eN or NN scattering?

25

Can we measure ecological sustainability? Landscape pattern as an indicator for naturalness and land use intensity at regional, national and European level

26

Can We Measure How Hot the Plaque Is? Not Yet, But…

27

Can we meet targets for biofuels and renewable energy in transport given the constraints imposed by policy in agriculture and energy?

28

Can We Minimize the Effects of Opioids on the Bowel and Still Achieve Adequate Pain Control?

29

Can we model organismic causes of working memory, efficiency and fluid intelligence? A meta-subjective perspective

30

Can We Modify Late Functional Outcome in Ebstein Anomaly by Altering Surgical Strategy?

31

Can we observe galaxies that recede faster than light ? —A more clear-cut answer

32

Can we observe the quark gluon plasma in cosmic ray showers

33

Can we optimise treatment of thrombosis?

34

Can we overcome automobile dependence? : Physical planning in an age of urban cynicism

35

Can we play Fun Gay? Disjuncture and difference, and the precarious mobilities of millennial queer youth narratives

36

Can we predict biological condition of stream ecosystems? A multi-stressors approach linking three biological indices to physico-chemistry, hydromorphology and land use

37

Can we predict crashes? The case of the Brazilian stock market

38

Can we Predict Fate of Bleeding in Early Pregnancy?

39

Can we predict habitat quality from space? A multi-indicator assessment based on an automated knowledge-driven system

40

Can we predict long-term sequelae after fractures of the clavicle based on initial findings? A prospective study with nine to ten years of follow-up

41

Can We Predict Long-Term Survival After Pulmonary Metastasectomy for Renal Cell Carcinoma?

42

Can We Predict Patients’ Cooperation During Phacoemulsification Surgery Under Topical Anesthesia?

43

Can we predict performance and spatial structure of two-species mixtures using only single species information from monocultures?

44

Can we predict performance and spatial structure of two-species mixtures using only single species information from monocultures?

45

Can we predict successful completion of the common foundation programme at interview?

46

Can we predict temperature-dependent chemical toxicity to marine organisms and set appropriate water quality guidelines for protecting marine ecosystems under different thermal scenarios?

47

Can we predict the duration of respiratory support in transient tachypnea of the newborn?

48

Can we predict the failure point of a loaded composite material? Original Research Article

49

Can we predict the fate of the Universe?

50

Can we predict the future food production? A sensitivity analysis

51

Can We Predict Thromboembolic Events in Low-Risk Patients Undergoing Catheter Ablation of Atrial Fibrillation?: The Hanging CHAD

52

Can we predict uranium bioavailability based on soil parameters? Part 1: Effect of soil parameters on soil solution uranium concentration

53

Can we predict uranium bioavailability based on soil parameters? Part 2: Soil solution uranium concentration is not a good bioavailability index

54

Can we predict which head and neck cancer survivors develop fears of recurrence?

55

Can we predict which patients with implantable cardioverter defibrillators receive appropriate shock therapy? A study of 155 patients

56

Can We Prepare IVF Culture Media Two Days Before Ovum Pick up Without Affecting Embryological Parameters? A Retrospective Case-Matched Study

57

Can we prepare our bodies over the year to cope with Ramadan fasting more easily? Imam Reza’s health and dietary recommendations for different months of the year

58

Can we prevent azole resistance in fungi?

59

Can We Prevent Breast Cancer?

60

Can We Prevent Heart Failure With Exercise?

61

Can we profile sex offenders? A review of sex offender typologies

62

Can We Provide Reperfusion Therapy to All Unselected Patients Admitted With Acute Myocardial Infarction?

63

Can we pull the plug on warfarin in atrial fibrillation?

64

Can we put aside the LNT dilemma by the introduction of the controllable dose?

65

Can we quantify the benefits of DMDs in multiple sclerosis?

66

Can we rationally design molecularly imprinted polymers?

67

Can we rationally design molecularly imprinted polymers? Original Research Article

68

Can we reach consensus between marine ecological models and DEB theory? A look at primary producers

69

Can we really grow new blood vessels?

70

Can we really learn from model pathogens?

71

Can we really measure the internal energy of hot nuclei with a 4π detection array? Original Research Article

72

Can we really measure the relative permeabilities using the micropore membrane method?

73

Can we really predict risk of cancer?

74

Can we reconcile consumer wishes and provider restraints?

75

Can we reconstruct browsing history and how far back? Lessons from Vaccinium parvifolium Smith in Rees

76

Can we recover information from concordant pairs in binary matched pairs?

77

Can We Reduce Salinity Effects by the Application of Humic Acid on Native Turfgrasses in order to Attain Sustainable Landscape?

78

Can We Reduce Secondary Surgical Interventions and Length of Hospitalization in Percutaneous Nephrolithotomy?

79

Can We Reduce Secondary Surgical Interventions and Length of Hospitalization in Percutaneous Nephrolithotomy?

80

Can we reduce the burden of musculoskeletal conditions? The European action towards better musculoskeletal health

81

Can we reduce the caesarean section rate?

82

Can We Re-Imagine Research So It Is Timely, Relevant and Responsive? Comment on “Experience of Health Leadership in Partnering with University-Based Researchers in Canada: A Call to ‘Re-Imagine’ Research”

83

Can we relate MeCP2 deficiency to the structural and chemical abnormalities in the Rett brain?

84

Can we reliably predict long-term mortality after exercise testing? An external validation

85

Can We Rely on Frozen Sections of a Rectal Biopsy for One-stage Trans-anal Pull-through Operation in Hirschsprung's Disease?

86

Can we rely on the multiplex ligation-dependent probe amplification method (MLPA) for prenatal diagnosis?

87

Can we Replace Arterial Blood Gas Analysis by Pulse Oximetry in Neonates with Respiratory Distress Syndrome, who are Treated According to INSURE Protocol?

88

Can we replace the 90-minute thrombolysis in myocardial infarction (TIMI) flow grades with those at 60 minutes as a primary end point in thrombolytic trials?

89

Can we reposition the preferred geological conditions necessary for an infiltration gallery? The development of a synthetic infiltration gallery Original Research Article

90

Can We Resolve Contradictions between Process Dissociation Models?

91

Can we RESOLVE the treatment of sepsis?

92

Can we restore the Colorado River delta?

93

Can we reverse the HIV/AIDS pandemic with an expanded response?

94

Can we screen for pelvic organ prolapse without a physical examination in epidemiologic studies?

95

Can we simulate regional groundwater flow in a karst system using equivalent porous media models? Case study, Barton Springs Edwards aquifer, USA

96

Can we skill and activate children through primary school physical education lessons? “move it groove it”—a collaborative health promotion intervention

97

Can We Slow Down the Global Increase of Adiposity?

98

Can we solve the mysteries of the National Vietnam Veterans Readjustment Study?

99

Can we stand the heat?

100

Can we start to think about consensus-oriented clinical practices?

101

Can we still beat “buy-and-hold” for individual stocks?

102

Can We STOP AF With Cryoballoon Ablation?

103

Can we stop national immunisation days before global eradication of poliomyelitis?

104

Can we study intelligence using the experimental method

105

Can we study quark matter in the quenched approximation? Original Research Article

106

Can we synthesise a dense bundle of quasi one-dimensional metallic wires?

107

Can we synthesise a dense bundle of quasi one-dimensional metallic wires?

108

Can we talk? How the cognitive neuroscience of attention emerged from neurobiology and psychology, 1980–2005

109

Can We Talk?: Importance of Random-Digit-Dial Surveys for Injury Prevention Research Review Article

110

Can We Target Smoking Groups More Effectively? A Study of Male and Female Heavy Smokers

111

Can We Tell How a Community Was Constructed? A Comparison of Five Evenness Indices for Their Ability to Identify Theoretical Models of Community Construction

112

Can We Treat Cognitive Deficits in Patients with Epilepsy?

113

Can we treat coronary artery disease with antibiotics?

114

Can We Trust a Compact Bacteriological Screening Test to Identify the Common Vaginal Pathogens?

115

Can we trust elemental abundances derived in late-type giants with the classical 1D stellar atmosphere models

116

Can We Trust Information?

117

Can we trust module-respect heuristics?

118

Can we trust module-respect heuristics?

119

Can we trust odor databases? Example of t- and n-butyl acetate

120

Can we trust PRA?

121

Can we trust PRA?

122

Can we trust the web?

123

Can we understand structural and tectonic processes and their products without appeal to a complete mechanics?

124

Can we unlock the potential of IGF-1R inhibition in cancer therapy?

125

Can we use area per surfactant as a quantitative test model of specific ion effects?

126

Can we use biomass produced from phytoremediation?

127

Can we use complex-valued fractional Brownian motion to derive a fractal space-time theory in micro-physics

128

Can we use disease to control biological invasion?—A theoretical research

129

Can we use disease to control biological invasion?—A theoretical research

130

Can we use erythrocytes for the study of the activity of the ubiquitous Na+/H+ exchanger (NHE-1) in essential hypertension?

131

Can we use fixed ambient air monitors to estimate population long-term exposure to air pollutants? The case of spatial variability in the Genotox ER study

132

Can We Use Heart Rate Recovery Information Generated by Supine Ergometry Exercise?

133

Can We Use Home Sleep Testing for the Evaluation of Sleep Apnea in Obese Pregnant Women?

134

Can we use in vitro fertilization tests to predict semen fertility?

135

Can we use indoor fungi as bioindicators of indoor air quality? Historical perspectives and open questions Review Article

136

Can We Use Placental Growth Factor-Based Tests to Assess Women With Suspected Pre-eclampsia?

137

Can we use serum gamma-glutamyl transferase levels to predict early mortality in stroke?

138

Can wealthy traders claim monopolies in common English words under the UK trade marks act 1994? British Sugar plc v. Robertson & Sons

139

Can Web 2.0 Enhance Community Participation in an Institutional Repository? The Case of PocketKnowledge at Teachers College, Columbia University Original Research Article

140

Can Weblogs and Microblogs Change Traditional Scientific Writing?

141

Can weblogs cause the emergence of social intelligence?: causal model of intention to continue publishing weblog in Japan

142

Can weighing lysimeter ET represent surrounding field ET well enough to test flux station measurements of daily and sub-daily ET? ☆

143

Can Weight Gain Predict the Outcome of Childhood Leukemia?

144

Can wetlands maintained for human use also help conserve biodiversity? Landscape-scale patterns of bird use of wetlands in an agricultural landscape in north India

145

Can white blood cell count be used as a predictor of atrial fibrillation following cardiac surgery? A short literature review

146

Can Wideband Absorbance Be Used in the Detection of Ossicular Chain Defects?

147

Can willingness to pay capture the value of altruism? An exploration of Sen’s notion of commitment

148

Can women in less-developed countries use a simplified medical abortion regimen?

149

Can Women Travel to The Policy-Making Level in Bangladesh? Rural Women’s Political Representation, Participation and Empowerment in the Context of Microfinance

150

Can women without visible pubococcygeal muscle in MR images still increase urethral closure pressures?

151

Can womenʹs autonomy impede male involvement in pregnancy health in Katmandu, Nepal?

152

Can wood ants distinguish between good and bad food patches on the forest floor?

153

Can wood quality justify local preferences for firewood in an area of caatinga (dryland) vegetation?

154

Can wooden poles be used to reconnect habitat for a gliding mammal?

155

Can Working Memory Be Trained through Learning an Additional Language? the effects of TPR versus PPP

156

Can world real interest rates explain business cycles in a small open economy?

157

Can worriers be winners? The association between worrying and job performance

158

Can Wrist Blood Pressure Oscillometer Be Used for Triage in an Adult Emergency Department?

159

Can yeast systems biology contribute to the understanding of human disease? Original Research Article

160

Can Yesterday’s Demand-Side Management Lessons Become Tomorrow’s Market Solutions?

161

Can Yin-Chai-Xiao-Du decoction be useful of COVID-19? the mechanism research based on network pharmacology

162

Can Yoga Be Considered as an Effective Supportive Psychological Intervention with an Impact on the Quality of Life for Breast Cancer Survivors?

163

Can You Adhere Me Now? Good

164

Can You Answer a Question for Me? Processing Indirect Speech Acts

165

Can you bank on GenBank?

166

Can you believe my eyes? The importance of interobserver reliability statistics in observations of animal behaviour

167

Can You Buy a Business Relationship?: On The Importance of Customer and Supplier Relationships in Acquisitions

168

Can you dig it? Use of excavation, a risky foraging tactic, by dugongs is sensitive to predation danger

169

Can you guess the game you are playing?

170

Can you hear the dinner bell? Response of cyprinid fishes to environmental acoustic cues

171

Can you judge a book by its cover? Evidence of self–stranger agreement on personality at zero acquaintance

172

Can you judge a book by its cover? Evidence of self–stranger agreement on personality at zero acquaintance

173

Can you move one eye only?

174

Can you pay people to be healthy?

175

Can You Predict What Happens When EuroSCORE Weds Biomarker?

176

Can you recommend a good book on indexing? Collected reviews on the organization of information : by Bella Hass Weinberg, with a Foreword by Linda K. Fetters and an Index by Susan Klement. Medford, NJ: American Society of Indexers/Information Today, 1998.

177

Can you recommend a good book on indexing?: A Response to the review

178

Can you see the writing on my wall?

179

Can you teach old dogs new tricks? On complementarity of human capital and incentives

180

Can you tickle yourself if you swap bodies with someone else?

181

Can you Trust a Single Data Source Exploratory Software Engineering Case Study?

182

Can younger students succeed where older students fail? An examination of third gradersʹ solutions of a division-with-remainder (DWR) problem

183

Can your institution’s name influence constituent response? An initial assessment of consumer response to college names

184

Can YouTube enhance student nurse learning?

185

Can Zerhouni create a bold, risk-taking NIH?

186

Can Zeta sperm selection method, recover sperm with higher DNA integrity compare to density gradient centrifugation?

187

Can Zinc Be an Option for Prevention of Corona Virus Disease 2019?

188

Can β-blocker therapy be withdrawn from patients with dilated cardiomyopathy?, ,

189

Can γ-radiometrics predict soil textural data and stoniness in different parent materials? A comparison of two machine-learning methods

190

Can δ13C abundance, water-soluble carbon, and light fraction carbon be potential indicators of soil organic carbon dynamics in Zoigê wetland?

191

CAN/[nbp]FeCl4 as a Reusable Catalytic System for Direct Conversion of Trimethylsilyl Ethers to Their Acetates Under Microwave Irradiation

192

Can’t Catch a Breath

193

Can’t see the wood for the trees, can’t see the trees for the numbers? Accounting education, sustainability and the Public Interest

194

Can’t shake that feeling: event-related fMRI assessment of sustained amygdala activity in response to emotional information in depressed individuals

195

196

Canada – Titanium Corp Inc – TiO2 feedstock from tar sand tailings

197

Canada & US: Clariant – masterbatch

198

Canada advises against use of phthalates in childrenʹs toys

199

Canada apologises to native people who suffered abuse

200

CANADA AS A NEW PLACE: THE IMMIGRANT’S EXPERIENCE

201

Canada bans Pigment Red 3 for use as cosmetics ingredient

202

Canada delays legislation on cheap drugs

203

Canada draws near to approving Africa drugs deal

204

Canada finally launches national HIV/AIDS strategy

205

Canada gets fund for health services research

206

Canada gets tough with reproductive technologies

207

Canada hits back at tobacco companies

208

Canada increases breast screening and research

209

Canada introduces “evidence-based” guidelines for breast-cancer care

210

Canada launches breast-cancer strategy

211

Canada lifts ban on blood donors with Creutzfeldt-Jacob disease

212

Canada makes vaccine biotech investment

213

Canada may ban Disperse Blue 19, PDDAM & Pigment Red 251

214

Canada moves to protect babies from chemical

215

Canada moves to stem health-research “brain drain”

216

Canada moves towards “whistle-blowing” law

217

Canada needs better drug reporting, says inquest

218

Canada outlines 10-year research strategy that will “take on the world”

219

Canada plans mental-health outreach

220

Canada post delivers energy conservation

221

Canada proposes strict tobacco controls

222

Canada puts Health Act up for negotiation

223

Canada reacts to water contamination

224

Canada rules no fetal rights

225

Canada sends out urgent appeal for blood

226

Canada shootings linked with abortion

227

Canada silences scientists that spoke out about BSE

228

Canada starts renewed effort against tobacco-industry advertising

229

Canada still seeking research code of ethics

230

Canada strengthens pandemic plan in wake of SARS

231

Canada Thistle [Cirsium arvense (L) Scop.] Response to Density of Cassida rubiginosa Müller (Coleoptera: Chrysomelidae) and Plant Competition

232

Canada to abolish fee-for-service in primary care?

233

Canada to change patent law to allow export of cheap drugs

234

Canada to define essential medical care

235

Canada to limit artificial reproduction technologies

236

Canada to overhaul blood system

237

Canada unveils plans for new blood authority

238

Canada upholds rights of pregnant women

239

Canada waits for “grandaddy” of health-reform studies

240

Canada, South Korea, Netherlands and Sweden: regulatory implications of the convergence of telecommunications, broadcasting and Internet services

241

Canada: Atlantic – barytes

242

Canada: Black Bull – kaolin

243

Canada: Canadian Wollastonite – wollastonite

244

Canada: Cancarb – carbon black

245

Canada: Clariant — plastics masterbatch

246

Canada: Clariant — plastics masterbatch

247

Canada: Ferrinov – anti-corrosion pigments from furnace flue-dust

248

Canada: Hillsborough/NW Pozzolan – kaolin

249

Canada: Optima – plastics masterbatch

250

Canada: QIT – TiO2 feedstock

251

Canada: Rio Tinto – TiO2 feedstock

252

Canada: Western Oil Sands & Altair – TiO2 feedstock & pigment

253

Canada: Western Oil Sands & Altair – TiO2 feedstock & pigment

254

Canada: What it is, What it can be, R. Martin, J. Milway. Toronto University Press, Toronto, ON (2012)

255

Canada: Whitemud – kaolin for cement

256

Canada: Whitemud – kaolin for cement

257

Canada: Whitemud – kaolin for cement

258

Canada’s constitutional separation of (wind) power

259

Canada’s energy perspectives and policies for sustainable development

260

Canada’s New Mental Disorder Disposition Provisions:: A Case Study of the British Columbia Criminal Code Review Board

261

Canada’s Pioneering Women of Vascular Surgery: A Historical Review

262

Canada’s program on nuclear hydrogen production and the thermochemical Cu–Cl cycle

263

Canada’s voluntary agreement on vehicle greenhouse gas emissions: When the details matte

264

Canadaʹs antismoking initiative goes ahead

265

Canadaʹs antitobacco stance even tougher

266

Canadaʹs Atlantic Coastal Action Program: A community-based approach to collective governance

267

Canadaʹs blood inquiry gains strength

268

Canadaʹs British Columbia attacks tobacco companies

269

Canadaʹs budget causes mixed emotions

270

Canadaʹs cancer costs rise

271

Canadaʹs centres of excellence will stay

272

Canadaʹs doctors post reward for abortionistsʹ killers

273

Canadaʹs doctors want technology investment

274

Canadaʹs doctors win

275

Canadaʹs drug industry put under pressure

276

Canadaʹs drug prices poorly controlled

277

Canadaʹs drug-cost burden on patients increases

278

Canadaʹs health care boosted before elections

279

Canadaʹs health ministry gains new chief

280

Canadaʹs health-care reform side tracked

281

Canadaʹs hepatitis C compensation derailed

282

Canadaʹs Liberals make solemn election vows

283

Canadaʹs Medicare principles defended

284

Canadaʹs Mental Health System

285

Canadaʹs ministers agree health package

286

Canadaʹs MRC and drug industry try to make amends

287

Canadaʹs new minerals and metals policy: Advancing the concept of sustainable development in the minerals and metals industry

288

Canadaʹs new prime minister vows to cut surgery wait lists

289

Canadaʹs new regulatory framework. Convergence, competition and the Information Highway

290

Canadaʹs ocean and maritime security a strategic forecast: A strategic forecast

291

Canadaʹs offer to host the ITER project

292

Canadaʹs pharmacists can sell prescribing data

293

Canadaʹs provinces tackle government for more money for Medicare

294

Canadaʹs Red Cross demands HCV-screening funds

295

Canadaʹs Red Cross on the offensive over its future role

296

Canadaʹs Red Cross sells blood assets

297

Canadaʹs research network virtually ready

298

Canadaʹs style of continuing medical education

299

Canadaʹs Supreme Court limits doctorʹs liability

300

Canadaʹs supreme court rejects broadcasterʹs appeal on doctorsʹ libel verdict

301

Canadaʹs university presidents “ecstatic” over funding for research

302

Canadaʹs unpopular health legislation passed

303

Canada-United States Chicken Trade: A Re-Evaluation

304

Canada-Wide Survey of the Nutritional Composition of Six Retail Pork Cuts

305

Canadian Aboriginal communities and medical service patterns for the management of injured patients: a basis for surveillance

306

Canadian Aboriginal peopleʹs experiences with HIV/AIDS as portrayed in selected English language Aboriginal media (1996–2000)

307

Canadian Aboriginal peopleʹs health and the Kelowna deal

308

Canadian Act may mean greater access to personal medical records

309

Canadian advanced life support capacities and future directions Original Research Article

310

Canadian Agricultural Safety Net Programs and Pressures for Change

311

Canadian agri-environmental indicators related to land quality: integrating census and biophysical data to estimate soil cover, wind erosion and soil salinity

312

Canadian AIDS doctor convicted of physicianassisted suicide

313

Canadian Alzheimer collaboration agreed

314

Canadian aquatic science and environmental legislation under threat

315

Canadian Association of Gastroenterology Indicators of Safety Compromise following Colonoscopy in Clinical Practice

316

Canadian Association of Gastroenterology: Strategic Plan 2016–2020

317

Canadian blood-donation prohibition for UK visitors

318

Canadian Bridge Design Code Provisions for Fiber-Reinforced Structures

319

Canadian budget gives healthcare a boost

320

Canadian ceramic breeder technology: recent results

321

Canadian cigarette packs to list toxins and hazards

322

Canadian collaboration networks: A comparative analysis of the natural sciences, social sciences and the humanities

323

Canadian compulsory community treatment laws: Recent reforms

324

Canadian court reaffirms reproductive rights

325

Canadian court says yes to tobacco advertising

326

Canadian court tells government to relax marijuana law for patients

327

Canadian C-spine Rule versus NEXUS in Screening of Clinically Important Traumatic Cervical Spine Injuries; a systematic review and meta-analysis

328

Canadian CT head rule study for patients with minor head injury: methodology for phase II (validation and economic analysis)

329

Canadian Dietary Fat Substitutions, 1955–93, and Coronary Heart Disease Costs

330

Canadian doctorsʹ leaders take charge of project to reduce medical error

331

Canadian doctorʹs murder charge dropped

332

Canadian doctorsʹ prescribing habits for sale

333

Canadian doctors produce charter of demands

334

Canadian doctors vote for two systems

335

Canadian drive to curb drug expenditure

336

Canadian east coast marine-protected areas: A review

337

Canadian epidemiologists examine elective surgery

338

Canadian evidence on long-run neutrality propositions

339

Canadian Exports of Livestock and Meat to the United States

340

Canadian federal government policy and Canadaʹs electronic information industry

341

Canadian Federal Government requirements and support tools for pollution prevention planning

342

Canadian fetal-rights case decided

343

Canadian finance plan plugs health gaps exposed by SARS

344

Canadian genomics project gets kick start

345

Canadian geomorphology 2000: Introduction

346

Canadian government abandon deal for victims of tainted blood

347

Canadian government addresses chemical pollution

348

Canadian government agencies develop e-mail management policies

349

Canadian government allows more patients to use marijuana

350

Canadian government makes guarantees on Medicare

351

Canadian government survives HCV vote

352

Canadian government urged to improve end-of-life care

353

Canadian government will revisit human-cloning legislation

354

Canadian greenhouse gas emissions: 1990–2000

355

Canadian group calls for more environmental health studies

356

Canadian Headache Society criteria for the diagnosis of acute migraine headache in the ED—do our patients meet these criteria?

357

Canadian Health and Food: The Links between Policy, Consumers, and Industry

358

Canadian health-care spending soars

359

Canadian hopes for low-cost drugs dashed

360

Canadian hospitals call for restrictions on single-use devices

361

Canadian House Dust Study: Population-based concentrations, loads and loading rates of arsenic, cadmium, chromium, copper, nickel, lead, and zinc inside urban homes Original Research Article

362

Canadian hydrogen safety program

363

Canadian hypertension society guidelines for ambulatory blood pressure monitoring

364

Canadian infection-control experts push for health reform

365

Canadian insights: The challenges of an integrated environmental assessment framework

366

Canadian institutes fund new initiatives in health research

367

Canadian Intellectual Property Office: backfile conversion project: 1992–1996

368

Canadian judge allows marijuana as therapy

369

Canadian kimberlites: Geological characteristics relevant to emplacement

370

Canadian Macromolecular Crystallography Facility (CMCF) 08ID-1 status update

371

Canadian Macromolecular Crystallography Facility (CMCF) 08ID-1 status update

372

Canadian Medical Association champions private medicine

373

Canadian Medical Associationʹ president guilty of misconduct

374

Canadian men need a healthier lifestyle

375

Canadian mercury inventories: the missing pieces

376

Canadian military malarial prophylaxis under scr utiny

377

Canadian Milling Practice : Edited by B. Damjanovic and J.R. Goode xi + 292 pages 22x 28.7 cm, hard cover, published by Canadian Institute of Mining, Metallurgy, and Petroleum, Montreal 2000. Price $80 ($65 for members, $45 for students) + postage ($10 Ca

378

Canadian MRC encourages private sector partnership

379

Canadian multicenter pilot trial of haploidentical donor transplantation

380

Canadian National Air Pollution Surveillance (NAPS) PM2.5 speciation program: Methodology and PM2.5 chemical composition for the years 2003–2008

381

Canadian National Breast Screening Study

382

Canadian national power quality survey: frequency and duration of voltage sags and surges at industrial sites

383

Canadian naturopathic practitioners: holistic and scientific world views

384

Canadian NOx/VOC Science Assessment: science and policy linkages

385

Canadian Occupational Performance Measure Supported by Talking Mats: An Evaluation of the Clinical Utility

386

Canadian officials criticised over soldiersʹ care

387

Canadian officials watch SARS-like mystery bug

388

Canadian Opinions on Refractive Surgery and Approaches to Presbyopia Correction

389

Canadian panel calls for review of drug-trial confidentiality agreements

390

Canadian Parliament finally agrees human reproduction research act

391

Canadian pastoral: promotional images of British colonization in Lower Canadaʹs Eastern Townships during the 1830s

392

Canadian patent profile: Some explorations in patent statistics Original Research Article

393

Canadian petrochemical plants blamed for gender imbalance

394

Canadian practitionersʹ perception of research work investigating the cost premiums, long-term costs and health and productivity benefits of green buildings

395

Canadian programme reverses high anaemia incidence

396

Canadian prohibition against immigrants with disabilities is challenged

397

Canadian province opens door to two-tier health service

398

Canadian provincial health ministers press for change

399

Canadian R&D abroad management practices

400

Canadian Red Cross fires secretary-general

401

Canadian Red Cross found negligent

402

Canadian regulation of private security in an international perspective

403

Canadian regulatory approach to ensuring the implementation of effective ageing management programs for nuclear power plants

404

Canadian report quantifies cost of medical errors

405

Canadian researchers awarded record damages

406

Canadian researchers respond to CMAJ crisis

407

Canadian respirologistʹs murder trial appeal quashed

408

Canadian retailing strategy: Challenges and change : William A. Crowe and Mark E. Siemonsen Nelson Canada, Scarborough, Ontario: (1996) 444 pp. ISBN 0 17 6055770

409

Canadian scientists urge government to develop antibiotic plan

410

Canadian scientists vindicated over whistleblowing

411

Canadian settlement guarantees world medical isotope supply

412

Canadian soldiers and doctors face torture allegations

413

Canadian space environment program and international living with a star Original Research Article

414

Canadian spending on prescription drugs is increasing

415

Canadian Steinernematid (Nematoda) Isolates and Their Infectivity, under Cold Conditions, to Greater Wax Moth (Galleria mellonella) Larvae

416

Canadian suppliers of mining goods and services: links between Canadian mining companies and selected sectors of the Canadian economy: Minerals and Metals Sector; Natural Resources Canada, 2000, xvi + 58pp., free upon request, ISBN 0-662-84954-7, softcove

417

Canadian tourist information and the UK: plans and perceptions

418

Canadian universities go shopping for research scientists

419

Canadian university publishes new rules to protect scientists

420

Canadian waters provide critical foraging habitat for leatherback sea turtles Original Research Article

421

Canadians allow targeted transfusion

422

Canadians are fighting fit, says government report

423

Canadians finally fill regulatory void with stem-cell bill

424

Canadians in Alabama: a perceptual study of dialect acquisition in adults

425

Canadians inquire into drug licensing

426

Canadians propose overhaul of research-ethics guidelines

427

Canadians still stung by WHOʹs SARS travel advisory

428

Canagliflozin-associated Peripheral Vascular Ischemia: A Case Report

429

Canal blocking strategies for hydrological restoration of degraded tropical peatlands in Central Kalimantan, Indonesia

430

Canal configuration of mandibular first premolars in an Egyptian population

431

Canal Configuration of Mesiobuccal Roots in Permanent Maxillary First Molars in Iranian Population: A Systematic Review

432

Canal of Nuck hernias

433

Canal preparation for prosthetic radial head replacement: rasping versus reaming

434

Canal surfaces in 4-dimensional Euclidean space

435

Canal Transportation and Centering Ability of ProTaper and SafeSider in Preparation of Curved Root Canals: A CBCT Evaluation

436

Canal Transportation and Centering Ability of Reciproc Blue, WaveOne Gold and ProTaper Next in Simulated Curved Canals

437

Canal Transportation and Centering Ability of Twisted File and Reciproc: A Cone-Beam Computed Tomography Assessment

438

Canal Transportation and Centering after Using PathFile and R-Pilot in Mesiobuccal Canals of Maxillary Molars Using Cone-Beam Computed Tomography

439

Canal Transportation and Centring Ability of Reciproc and Reciproc Blue With or Without Use of Glide Path Instruments: A CBCT Study

440

Canal water treatment with rapid sand filtration

441

Canaletto’s paintings open a new window on the relative sea-level rise in Venice

442

Canalicular adenoma of the hard palate: A rare case report

443

Canalicular and Naolacrimal Duct Blockage: An Ocular ide Effect Aociated With the Antineoplatic Drug -1

444

Canalicular bile formation: beyond single transporter functions

445

Canalicular fluid flow induced by bending of a long bone

446

Canalis Sinuosus Damage after Immediate Dental Implant Placement in the Esthetic Zone

447

Canalization as a non-genetic source of adaptiveness during morphogenesis: experimental evidence from analysis of reproductive development in Sorghum bicolor

448

Canalization of development and ecdysteroid timing during the last instar in lubber grasshoppers

449

Canals and Communities. Small-scale Irrigation Systems, Edited by J. Mabry, University of Arizona Press, 1996. ISBN 0816515921, pp. 273

450

Canard phenomenon for an SIS epidemic model with nonlinear incidence

451

Canard solution and its asymptotic approximation in a second-order nonlinear singularly perturbed boundary value problem with a turning point

452

Canard solutions of two-dimensional singularly perturbed systems

453

Canards and mixed-mode oscillations in a forest pest model

454

455

CANARD-WING INTERACTIONS IN SUBSONIC FLOW

456

Canary current upwelling: More or less?

457

Canary in the coalmine: Norwegian attitudes towards climate change and extreme long-haul air travel to Aotearoa/New Zealand

458

Canary islands aborigin sex determination based on mandible parameters contrasted by amelogenin analysis

459

Canataxpropellane, a novel taxane with a unique polycyclic carbon skeleton (tricyclotaxane) from the needles of Taxus canadensis

460

Canavalia ensiformis urease, Jaburetox and derived peptides form ion channels in planar lipid bilayers

461

Canavan disease: a monogenic trait with complex genomic interaction

462

Canavanine content in sword beans (Canavalia gladiata): Analysis and effect of processing

463

CaNb2O6 ceramics prepared by a reaction-sintering process

464

c-ANCA as a marker of Wegenerʹs disease

465

c-ANCA as a serological pitfall

466

C-ANCA Positive Vasculitis in a Case of Amyloidosis

467

Cancarb appoints European agents for its Thermax thermal blacks

468

CAN-catalyzed syntheses of 3,4-dihydroquinoxalin-2-amine derivatives based on isocyanides

469

CAN-catalyzed three-component reaction between anilines and alkyl vinyl ethers: stereoselective synthesis of 2-methyl-1,2,3,4-tetrahydroquinolines and studies on their aromatization

470

471

Canceling out both the real and the spectral lines

472

Canceling print serials in favor of electronic: criteria for decision making

473

Cancellable biometerics featuring with tokenised random number

474

Cancellable biometrics and annotations on BioHash

475

Cancellation among finite unary algebras Original Research Article

476

Cancellation and Focus: The Role of Shared and Unique Features in the Choice Process

477

Cancellation Conditions for Finite Two-Dimensional Additive Measurement

478

Cancellation errors in an integral for calculating magnetic field from reduced scalar potential

479

Cancellation in cyclic consecutive systems

480

Cancellation is exponentially powerful for computing the determinant

481

Cancellation of bending-induced birefringence in single-mode fibers: application to Faraday sensors

482

Cancellation of Capacitor Parasitic Parameters for Noise Reduction Application

483

Cancellation of digraphs over the direct product

484

Cancellation of elective oral and maxillofacial operations

485

Cancellation of Elective Surgeries in a Tertiary Care Hospital in North India

486

Cancellation of fine-structure splitting in quantum dots by a magnetic field

487

Cancellation of Harmonic Interference by Baseline Shifting of Wavelet Packet Decomposition Coefficients

488

Cancellation of heat effects in catalytic distillation

489

Cancellation of image crosstalk in time-sequential displays of stereoscopic video

490

Cancellation of Infrared Divergences at Finite Temperature

491

cancellation of land certificate based on the court decision in indonesian legal system

492

CANCELLATION OF MASS-LOADING EFFECTS OF TRANSDUCERS AND EVALUATION OF UNMEASURED FREQUENCY RESPONSE FUNCTIONS

493

Cancellation of operations in Saudi Arabian hospitals: Frequency, reasons and suggestions for improvements

494

Cancellation of polarized impulsive noise using an azimuth-dependent conditional mean estimator

495

Cancellation of projective modules over regular rings with comparability Original Research Article

496

Cancellation of renormalon ambiguities in the heavy quark effective theory Original Research Article

497

Cancellation of second-order intermodulation distortion and enhancement of IIP2 in common-source and common-emitter RF transconductors

498

Cancellation of Series-Loss Resistance in UWB Active Inductors using RC Feedback

499

Cancellation of Simulated Environmental Noise as a Tool for Measuring Vocal Performance During Noise Exposure

500

Cancellation of star light generated by a nearby star–planet system upon detection with a rotationally-shearing interferometer

501

Cancellation of Sudakov logarithms in radiative decays of quarkonia Original Research Article

502

Cancellation of the Heating Piston Effect by Convective Enhancement of a Cooling Piston Effect

503

Cancellation problem of preconditioning method at low Mach numbers

504

Cancellation properties for quotient divisible groups

505

Cancellation properties of products of graphs

506

Cancellation Properties of Projective Modules over Laurent Polynomial Rings Original Research Article

507

Cancellation Properties of Projective Modules over Laurent Polynomial Rings Original Research Article

508

Cancellation provisions in Australiaʹs Commonwealth-managed fisheries

509

Cancellation task in very low educated people

510

Cancellation techniques in underwater scattering of acoustic signals

511

Cancellation Theorems Related to Conjectures of Alperin and Dade

512

Cancellations in ambulatory day surgery: Ten years observational study

513

Cancellations in day-case ENT surgery

514

Cancellations in neutrinoless double beta decay and the neutrino mass matrix Original Research Article

515

Cancellative pairs of families of sets

516

CancellativeAbelianMonoids and Related Structures in Refutational Theorem Proving (Part I)

517

CancellativeAbelianMonoids and Related Structures in Refutational Theorem Proving (Part II)

518

Cancellativity properties for t-norms and t-subnorms

519

Cancelled IGF-1 trials bode ill for diabetic patients

520

Cancelling Jüttner distributions for space-like freeze-out

521

Cancelling quadratic divergences without supersymmetry Original Research Article

522

Cancelling vibrations in flexible articulated structures using non-causal inverse dynamics

523

Cancellous and cortical bone mineral density around an elastic press-fi t socket in total hip arthroplasty

524

Cancellous and cortical morselized allograft in revision total hip replacement:: A biomechanical study of implant stability

525

Cancellous bone architecture: Advantages of nonorthogonal trabecular alignment under multidirectional joint loading

526

Cancellous bone biomechanics

527

Cancellous bone lamellae strongly affect microcrack propagation and apparent mechanical properties: Separation of patients with osteoporotic fracture from normal controls using a 2D nonlinear finite element method (biomechanical stereology)

528

Cancellous bone mechanical properties from normals and patients with hip fractures differ on the structure level, not on the bone hard tissue level

529

Cancellous bone microdamage in the proximal femur: influence of age and osteoarthritis on damage morphology and regional distribution

530

Cancellous bone repair using bovine trabecular bone matrix particulates

531

Cancellous impaction and cortical strut allografting for revision shoulder arthroplasty: A case report

532

533

Cancer – Blame it all on viruses! Bladder tumours in cattle and sarcoids in horses may help us understand the relationship between some cancers and viruses

534

Cancer Risk in Pakistan Due to Natural Environmental Pollutants

535

Cancer “challenge” to limited-resource countries

536

Cancer ameliorating potential of Phyllanthus amarus: In vivo and in vitro studies against Aflatoxin B1 toxicity

537

Cancer among Farmers: A Meta-Analysis

538

Cancer and a Fatiguing Illness in Northern Nevada—A Causal Hypothesis

539

Cancer and aging: The molecular pathways

540

Cancer and Body Composition: An Association of Global Relevance

541

Cancer and comorbidity in older patients: A descriptive profile

542

Cancer and Complications of Peptic Ulcer in Type 2 Diabetes Mellitus patients at Wasit province, Iraq

543

cancer and covid-19: the synergistic burden on mental health status of patients with cancer

544

Cancer and Emotion; the Scope of Psycho‐Socio‐Oncology

545

Cancer and Emotion; The Scope of Psycho‐Socio‐Oncology: At the Time of Diagnosis

546

Cancer and Emotion; The Scope of Psycho-Socio-Oncology: At the Time of Treatment

547

Cancer and globalization

548

Cancer and HIV infection in Rwanda

549

Cancer and incontinence

550

Cancer and inflammation: A complex relationship

551

Cancer and its Treatment in Main Ancient Books of Islamic Iranian Traditional Medicine (7th to 14th Century AD)

552

Cancer and Low Levels of Plasma Cholesterol: The Relevance of Cholesterol Precursors and Products to Incidence of Cancer

553

Cancer and male infertility

554

Cancer and mutant DNA in blood plasma

555

Cancer and natural medicine: Textbook of basic science and clinical research: By John Boik, Oregon Medical Press, 1996

556

Cancer and Non-Cancer Risk of Arsenic in Drinking Water: A Case Study

557

Cancer and nonextensive statistics

558

Cancer and ovarian tissue cryopreservation

559

Cancer and psychosocial distress: frequent companions

560

Cancer and self-help: Bridging the troubled Waters of childhood illness : By Mark A. Chesler and Barbara K. Chesney. The University of Wisconsin Press, Madison, WI, 1995. 416 pp

561

Cancer and the human genome: no quick fix

562

Cancer and the meaning of work

563

Cancer and thromboembolic disease: how important is the risk of thrombosis?

564

Cancer and thromboembolic disease: pathogenic mechanisms

565

Cancer and thrombosis revisited

566

Cancer and venous thromboembolism

567

Cancer and Women’s Health

568

Cancer and wood-related occupational exposure in the Amazon region of Brazil

569

Cancer anorexia and cachexia

570

Cancer anorexia: a model for the understanding and treatment of secondary anorexia

571

Cancer anorexia: new pathogenic andtherapeutic insights

572

Cancer Antigen 125 (CA125), Human Epididymis Protein 4 (HE4), Risk of Malignancy Index (RMI), and Risk of Ovarian Malignancy Algorithm (ROMA) as Diagnostic Tests in Ovarian Cancer

573

Cancer Antigens (CEA and CA 19-9) as Markers of Advanced Stage of Colorectal Carcinoma

574

Cancer as a Complex Genetic Trait: Tumor Susceptibility in Humans and Mouse Models

575

Cancer as an Embryological Phenomenon and Its Developmental Pathways: A Hypothesis regarding the Contribution of the Noncanonical Wnt Pathway

576

Cancer associated with obstetric delivery: results of linkage with the California cancer registry

577

Cancer biology and necrotic changes in metastatic lymph nodes and survival of colon cancer patients

578

Cancer biology for the clinic and the lab

579

Cancer biomarker and neurotransmitters recognition by molecularly imprinted xero-gels

580

Cancer Biomarkers

581

Cancer biomarkers

582

Cancer biomarkers detection using 3D microstructured protein chip: Implementation of customized multiplex immunoassay

583

Cancer Biomarkers: Closer to Delivering on their Promise

584

Cancer Biopsy in Ancient Persian Medicine: Do or Not to Do!

585

Cancer bio-repository

586

Cancer bronchique localement évolué : qu’apporte la radiothérapie avec modulation d’intensité rotationnelle ?

587

Cancer bronchique localement évolué : qu’apporte la radiothérapie avec modulation d’intensité rotationnelle ?

588

Cancer bronchique non à petites cellules de l’apex pulmonaire et chimioradiothérapie de haute dose : expérience du centre hospitalier Lyon-Sud

589

Cancer bronchique non à petites cellules de l’apex pulmonaire et chimioradiothérapie de haute dose : expérience du centre hospitalier Lyon-Sud

590

Cancer bronchique non à petites cellules localement évolué : place de la chimioradiothérapie exclusive

591

Cancer bronchique non à petites cellules: mise au point en 1998

592

Cancer bronchique : le drainage lymphatique

593

Cancer burden and trends in the asian pacific RIM region

594

Cancer cachexia

595

Cancer cachexia and its treatment with fish-oil-enriched nutritional supplementation

596

Cancer Cachexia, Malnutrition, and Tissue Protein Turnover in Experimental Animals

597

Cancer Cachexia, Malnutrition, and Tissue Protein Turnover in Experimental Animals

598

Cancer cachexia: Measured and predicted resting energy expenditures for nutritional needs evaluation

599

Cancer cachexia: Metabolic alterations and clinical manifestations

600

Cancer Cancer vaccines: a road map for the next decade

601

Cancer care during the natural disasters, the lessons learned from Kermanshah Earthquake in 2017

602

Cancer Care Ontario guaiac fecal occult blood test (FOBT) laboratory standards: Evidentiary base and recommendations

603

Cancer cell detection in tissue sections using AFM

604

Cancer cell dissemination during curative surgery for colorectal liver metastases

605

Cancer Cell Dynamics in Presence of Telomerase Inhibitors: Analysis of In Vitro Data

606

Cancer Cell Invasion: Treatment and Monitoring Opportunities in Nanomedicine

607

Cancer Cell Metabolism: Warburg and Beyond

608

Cancer Cell progression

609

Cancer Cell Separation Using Passive Mechanisms: a Review

610

Cancer cell separator using size-dependent filtration in microfluidic chip

611

Cancer Cells Display Profound Intra- and Interline Variation following Prolonged Exposure to Antimitotic Drugs

612

Cancer cells isolated from malignant pleural and peritoneal effusions inhibit phospholipase A2 activity in human polymorphonuclear leukocytes

613

Cancer Cells Release a Covalent Complex Containing Disulfide-Linked Domains from Urinary Plasminogen Activator, Neural Cell Adhesion Molecule, and Haptoglobin α and β Chains

614

Cancer Cells Treated by Clusters of Copper Oxide Doped Calcium Silicate

615

Cancer chemoprevention by dietary chlorophylls: A 12,000-animal dose–dose matrix biomarker and tumor study

616

Cancer chemoprevention with garlic and its constituents

617

Cancer Chemoprevention. Vol. 2: Strategies for Cancer Chemoprevention.G.J. Kellof, E.T. Hawk and C.C. Sigman, Editors, Humana Press, Totowa (2005).

618

Cancer Chemoprevention. Volume I. Promising Cancer Chemopreventive Agents.G.J. Kelloff, E. T. Hawk and C.C. Sigman, Editors, P. Humana Press, Totowa (2004)

619

Cancer chemoprevention: A radical perspective

620

Cancer chemopreventive activity of 3,5,6,7,8,3′,4′-heptamethoxyflavone from the peel of citrus plants

621

Cancer chemopreventive activity of 3β-methoxyserrat-14-en-21β-ol and several serratane analogs on two-stage mouse skin carcinogenesis

622

Cancer chemopreventive activity of Achyranthes aspera leaves on Epstein–Barr virus activation and two-stage mouse skin carcinogenesis

623

Cancer chemopreventive activity of acridone alkaloids on Epstein–Barr virus activation and two-stage mouse skin carcinogenesis

624

Cancer chemopreventive activity of an iridoid glycoside, 8-acetylharpagide, from Ajuga decumbens

625

Cancer chemopreventive activity of carotenoids in the fruits of red paprika Capsicum annuum L.

626

Cancer chemopreventive activity of euglobal-G1 from leaves of Eucalyptus grandis

627

Cancer chemopreventive activity of flavanones on Epstein–Barr virus activation and two-stage mouse skin carcinogenesis

628

Cancer chemopreventive activity of majonoside-R2 from Vietnamese ginseng, Panax vietnamensis

629

Cancer chemopreventive activity of naphthoquinones and their analogs from Avicennia plants

630

Cancer chemopreventive activity of phenylpropanoid esters of sucrose, vanicoside B and lapathoside A, from Polygonum lapathifolium

631

Cancer chemopreventive activity of phenylpropanoids and phytoquinoids from Illicium plants

632

Cancer chemopreventive activity of serratane-type triterpenoids on two-stage mouse skin carcinogenesis

633

Cancer chemopreventive activity of synthetic colorants used in foods, pharmaceuticals and cosmetic preparations

634

Cancer chemopreventive agents, 4-phenylcoumarins from Calophyllum inophyllum

635

Cancer chemopreventive agents, labdane diterpenoids from the stem bark of Thuja standishii (Gord.) Carr

636

Cancer chemopreventive agents, serratane-type triterpenoids from Picea jezoensis

637

Cancer chemopreventive and therapeutic potential of resveratrol: Mechanistic perspectives

638

Cancer chemopreventive effect of dietary Zataria multiflora essential oils

639

Cancer chemopreventive effect of orally administrated lupane-type triterpenoid on ultraviolet light B induced photocarcinogenesis of hairless mouse

640

Cancer chemopreventive effect of quassinoid derivatives. Introduction of side chain to shinjulactone C for enhancement of inhibitory effect on Epstein–Barr virus activation

641

Cancer chemopreventive effects of constituents of Caesalpinia ferrea and related compounds

642

Cancer chemopreventive effects of oral feeding α-tocopherol on ultraviolet light B induced photocarcinogenesis of hairless mouse

643

Cancer chemopreventive effects of Pinus Maritima bark extract on ultraviolet radiation and ultraviolet radiation-7,12,dimethylbenz(a)anthracene induced skin carcinogenesis of hairless mice

644

Cancer chemopreventive effects of polyunsaturated fatty acids

645

Cancer Chemo-Preventive Effects of Red Propolis: a System Biology Approach

646

Cancer chemopreventive oltipraz generates superoxide anion radical

647

Cancer Chemoprotection by Oltipraz: Experimental and Clinical Considerations

648

Cancer chemotherapy – ribonucleases to the rescue Review Article

649

Cancer Chemotherapy and Biotherapy

650

Cancer chemotherapy in the older cancer patient

651

Cancer chemotherapy optimization under evolving drug resistance Original Research Article

652

Cancer chemotherapy with indole-3-carbinol, bis(3′-indolyl)methane and synthetic analogs

653

Cancer chemotherapy, biodiversity, public and private property: the case of the anti-cancer drug Taxol

654

Cancer chemotherapy: A SN-38 (7-Ethyl-10-hydroxycamptothecin) glucuronide prodrug for treatment by a PMT (Prodrug monoTherapy) strategy

655

Cancer chez le sujet âgé : place du dépistage gériatrique dans la décision thérapeutique

656

Cancer chez le sujet âgé : place du dépistage gériatrique dans la décision thérapeutique

657

Cancer Classification in Microarray Data using a Hybrid Selective Independent Component Analysis and υ‑Support Vector Machine Algorithm

658

Cancer Classification with a Cost-Sensitive Naive Bayes Stacking Ensemble

659

Cancer Control at the Workplace: The Working Well Trial

660

Cancer Control strategy in the world, a review article

661

Cancer control: a reminder of the need for a balanced approach between prevention and treatment

662

Cancer cutané et xéroderma pigmentosum

663

Cancer cutané et xéroderma pigmentosum

664

Cancer de l’endomètre de stade I

665

Cancer de l’estomac : doses et volumes-cibles

666

Cancer de l’estomac. Le point thérapeutique en 2008

667

Cancer de la langue : expérience de l’Institut national d’oncologie de Rabat, à propos de 60 cas

668

Cancer de la langue : expérience de l’Institut national d’oncologie de Rabat, à propos de 60 cas

669

Cancer de la prostate

670

Cancer de la prostate 2010. Innovations thérapeutiques

671

Cancer de la prostate chez l’homme de moins de 50 ans : à propos de 26 cas

672

Cancer de la prostate chez l’homme de moins de 50 ans : à propos de 26 cas

673

Cancer de la prostate localisé et radiothérapie conformationnelle avec modulation d’intensité : quels sont les paramètres dosimétriques les plus pertinents pour prédire la toxicité digestive aiguë ?

674

Cancer de la prostate localisé et radiothérapie conformationnelle avec modulation d’intensité : quels sont les paramètres dosimétriques les plus pertinents pour prédire la toxicité digestive aiguë ?

675

Cancer de la prostate localisé, à risque intermédiaire ou élevé, dont le traitement a été une radiothérapie externe et incluant une curiethérapie de haut débit de dose : expérience du pôle régional de cancérologie de Poitou-Charentes

676

Cancer de la prostate localisé, à risque intermédiaire ou élevé, dont le traitement a été une radiothérapie externe et incluant une curiethérapie de haut débit de dose : expérience du pôle régional de cancérologie de Poitou-Charentes

677

Cancer de la thyroïde après exposition aux rayonnements ionisants

678

Cancer de lʹœsophage : répercussion des thérapeutiques néoadjuvantes sur la morbidité et la mortalité opératoire

679

Cancer de prostate et RCMI guidée par l’image : absence de corrélation entre paramètres dose/volume des organes à risque et toxicité tardive

680

Cancer de prostate et RCMI guidée par l’image : absence de corrélation entre paramètres dose/volume des organes à risque et toxicité tardive

681

Cancer de prostate localisé. Que dire au patient ?

682

Cancer de prostate : doses et volumes cibles

683

Cancer death epidemics in United States Black males: Evaluating courses, causation, and cures

684

CANCER DEATH RATES AND BACKGROUND RADIATION

685

Cancer detection and mammogram volume of radiologists in a population-based screening programme

686

Cancer detection from textual data using a combination of machine learning approach

687

Cancer Detection Using Aritifical Neural Network and Support Vector Machine: A Comparative Study

688

Cancer Development and Electromagnetic Fields in Near Future

689

Cancer diagnosis by autofluorescence of blood components

690

Cancer Diagnosis Disclosure: What is the Right Thing to Do?

691

Cancer Diagnosis in Endoscopic Images using Discrete Wavelet Transform

692

Cancer diagnosis, treatment, and survival in Indigenous and non-Indigenous Australians: a matched cohort study

693

Cancer Disclosure in Iran: Attitude of Patients and Their Families

694

Cancer disclosure in Japan: Historical comparisons, current practices

695

Cancer distress screening: Needs, models, and methods

696

Cancer dose–response assessment for acrylonitrile based upon rodent brain tumor incidence: Use of epidemiologic, mechanistic, and pharmacokinetic support for nonlinearity

697

Cancer driver mutations in protein kinase genes

698

Cancer du canal anal : expérience de l’Institut national d’oncologie de Rabat, à propos de 110 cas

699

Cancer du canal anal : expérience de l’Institut national d’oncologie de Rabat, à propos de 110 cas

700

Cancer du cavum au centre tunisien : à propos de 525 cas

701

Cancer du cavum au centre tunisien : à propos de 525 cas

702

Cancer du cavum chez le sujet jeune

703

Cancer du cavum chez le sujet jeune

704

Cancer du cavum chez les sujets âgés : expérience d’un centre tunisien

705

Cancer du cavum chez les sujets âgés : expérience d’un centre tunisien

706

Cancer du cavum dans l’ouest algérien : à propos de 578 cas traités à Oran, Algérie

707

Cancer du cavum dans l’ouest algérien : à propos de 578 cas traités à Oran, Algérie

708

Cancer du cavum dans la région de Marrakech. Expérience du service d’oncologie du centre hospitalier universitaire Mohammed-VI de Marrakech

709

Cancer du cavum dans la région de Marrakech. Expérience du service d’oncologie du centre hospitalier universitaire Mohammed-VI de Marrakech

710

Cancer du cavum dans le centre tunisien : facteurs pronostiques

711

Cancer du cavum dans le centre tunisien : facteurs pronostiques

712

Cancer du cavum du sujet âgé

713

Cancer du cavum du sujet âgé

714

Cancer du cavum et syndromes paranéoplasiques

715

Cancer du cavum et syndromes paranéoplasiques

716

Cancer du col utérin

717

Cancer du col utérin chez la femme jeune : à propos de 96 cas au Centre d’oncologie du CHU Ibn Rochd de Casablanca

718

Cancer du col utérin chez la femme jeune : à propos de 96 cas au Centre d’oncologie du CHU Ibn Rochd de Casablanca

719

Cancer du col utérin stades IB et II opérable : comparaison rétrospective entre curiethérapie utérovaginale préopératoire et chirurgie première suivies d’une radiothérapie

720

Cancer du col utérin : expérience du Maroc, à propos de 696 cas

721

Cancer du col utérin : expérience du Maroc, à propos de 696 cas

722

Cancer du larynx chez le sujet âgé

723

Cancer du larynx chez le sujet âgé

724

Cancer du larynx : expérience de l’institut national d’oncologie de Rabat, à propos de 404 cas

725

Cancer du larynx : expérience de l’institut national d’oncologie de Rabat, à propos de 404 cas

726

Cancer du nasopharynx chez l’enfant et l’adolescent : expérience du service de radiothérapie et d’oncologie Ibn-Rochd de Casablanca

727

Cancer du nasopharynx chez l’enfant et l’adolescent : expérience du service de radiothérapie et d’oncologie Ibn-Rochd de Casablanca

728

Cancer du nasopharynx dans l’Ouest algérien : résultats à long terme et facteurs pronostiques dans une cohorte de 200 cas

729

Cancer du nasopharynx dans l’Ouest algérien : résultats à long terme et facteurs pronostiques dans une cohorte de 200 cas

730

Cancer du pancréas localement évolué non resécable : chimioradiothérapie d’induction suivie de chimiothérapie par gemcitabine contre chimiothérapie exclusive par gemcitabine : résultats définitifs de l’étude de phase III 2000–2001de la FFCD et de la SFRO

731

Cancer du rectum avec métastases synchrone

732

Cancer du rectum avec métastases synchrone

733

Cancer du rectum chez le sujet de moins de 40 ans

734

Cancer du rectum chez le sujet de moins de 40 ans

735

Cancer du rectum localement évolué : place du boost tumoral en chimioradiothérapie concomitante préopératoire, étude rétrospective portant sur 75 cas

736

Cancer du rectum localement évolué : place du boost tumoral en chimioradiothérapie concomitante préopératoire, étude rétrospective portant sur 75 cas

737

Cancer du rectum : volumes cibles de la radiothérapie préopératoire

738

739

Cancer du sein bilatéral après maladie de Hodgkin. Particularités clinico-histologiques et possibilités thérapeutiques: analyse de 13 cas

740

Cancer du sein chez la femme âgée

741

Cancer du sein chez la femme âgée

742

Cancer du sein chez la femme âgée de plus de 70 ans : expérience de l’Institut national d’oncologie de Rabat

743

Cancer du sein chez la femme âgée de plus de 70 ans : expérience de l’Institut national d’oncologie de Rabat

744

Cancer du sein chez la femme de moins de 40 ans dans la région de Marrakech

745

Cancer du sein chez la femme de moins de 40 ans dans la région de Marrakech

746

Cancer du sein chez la femme jeune au Maroc

747

Cancer du sein chez la personne âgée : place de la radiothérapie ?

748

Cancer du sein chez la personne âgée : place de la radiothérapie ?

749

Cancer du sein d’emblée métastatique : impact de l’irradiation locorégionale exclusive sur la survie globale

750

Cancer du sein d’emblée métastatique : impact de l’irradiation locorégionale exclusive sur la survie globale

751

Cancer du sein de la femme de moins de 35 ans

752

Cancer du sein de la femme de moins de 35 ans

753

Cancer du sein et radiothérapie peropératoire par électrons : revue des 100 premières patientes traitées à l’institut Jules-Bordet

754

Cancer du sein et radiothérapie peropératoire par électrons : revue des 100 premières patientes traitées à l’institut Jules-Bordet

755

Cancer du sein et ultrasons : de l’imagerie au traitement des cancers

756

Cancer du sein et ultrasons : de l’imagerie au traitement des cancers

757

Cancer du sein inflammatoire au centre hospitalier universitaire Hassan-II de Fès : à propos de 41 cas

758

Cancer du sein inflammatoire au centre hospitalier universitaire Hassan-II de Fès : à propos de 41 cas

759

Cancer du sein localement évolué non inflammatoire traité par association de chimiothérapie et de radiothérapie à dose préopératoire : réactualisation des résultats d’une série de 120 patientes

760

Cancer du sein métastatiques : intérêt du CA 15-3

761

Cancer du sein métastatiques : intérêt du CA 15-3

762

Cancer du sein négligé et localement évolué : quelle réalité ? Réflexion à propos de deux cas sur l’optimisation de la prise en charge multidisciplinaire

763

Cancer du sein secondaire chez l’homme après traitement pour maladie de Hodgkin. À propos d’un cas et revue de la littérature

764

Cancer du sein traité exclusivement par l’association d’une irradiation externe et d’une curiethérapie exclusive : résultats à long terme

765

Cancer du sein : comparaison dosimétrique entre la technique des filtres en coin et celle « champ dans le champ »

766

Cancer du sein : comparaison dosimétrique entre la technique des filtres en coin et celle « champ dans le champ »

767

Cancer du sein. Questions et réponses au quotidien, J Saglier, EC Antoine. Masson, New York (1996), 125

768

Cancer du canal anal : comparaison dosimétrique entre radiothérapie trimensionnelle classique et par modulation d’intensité

769

Cancer du canal anal : comparaison dosimétrique entre radiothérapie trimensionnelle classique et par modulation d’intensité

770

Cancer education among primary care physicians in an underserved community

771

Cancer epidemiology and trends in Sistan and Baluchestan province, Iran

772

Cancer Epidemiology in Lebanon

773

Cancer Epidemiology in Radiation Oncology: An Institutional Experience From North India During 2016-2022

774

Cancer Epidemiology: The International Journal of Cancer Epidemiology, Detection and Prevention

775

Cancer epigenetics as biomarkers of clinical significance

776

Cancer epigenetics is no Mickey Mouse

777

Cancer epigenetics is no Mickey Mouse

778

Cancer Epigenetics: From Mechanism to Therapy

779

CANCER ESOPHAGUS: AN AUDIT OF CURRENT MANAGEMENT FOR YEMENI PATIENTS

780

Cancer Events After Acute or Chronic Exposure to Sulfur Mustard: A Review of the Literature

781

Cancer experts square up for European funds

782

Cancer familiarity status in patients with early brest cancer: Our experience

783

Cancer fatalism among african-americans: A review of the literature

784

Cancer Feature Selection and Classification Using a Binary Quantum-Behaved Particle Swarm Optimization and Support Vector Machine

785

Cancer gene may move quickly into skin clinics

786

Cancer gene therapy targeting cellular apoptosis machinery

787

Cancer genes and molecular oncology in the clinic

788

Cancer gene-therapy: clinical trials

789

Cancer Genetics and Cytogenetics

790

Cancer Genetics and Epigenetics: Two Sides of the Same Coin?

791

Cancer genetics and genomics of human FOX family genes

792

Cancer Genetics and the Cardiotoxicity of the Therapeutics

793

Cancer genome sequencing: Understanding malignancy as a disease of the genome, its conformation, and its evolution

794

Cancer Genomes Evolve by Pulverizing Single Chromosomes

795

Cancer genomics

796

Cancer Genomics: The Road Ahead

797

Cancer groups meet in Edinburgh

798

cancer has an independent association with death in hospitalized patients with covid-19: a single-center study in iran

799

Cancer hazard identification and qualitative risk assessment

800

Cancer heterogeneity and “The Struggle for Existence”: Diagnostic and analytical challenges

801

Cancer hopes and setbacks

802

Cancer immunomics: Using autoantibody signatures in the early detection of prostate cancer

803

Cancer immunoprevention: tracking down persistent tumor antigens

804

Cancer immunosurveillance, immunoediting and inflammation: independent or interdependent processes?

805

Cancer immunotherapy – broader considerations

806

Cancer Immunotherapy Using Microfluidic Systems

807

Cancer immunotherapy, mathematical modeling and optimal control

808

Cancer immunotherapy: novel strategies and clinical experiences

809

Cancer immunotherapy: simply cell biology?

810

Cancer immunotherapyʹs renaissance

811

Cancer in home care: Unintended weight loss and ethical challenges. A cross-sectional study of older people at 11 sites in Europe

812

Cancer in Kenya: types and infection-attributable. Data from the adult population of two National referral hospitals (2008-2012)

813

Cancer in Korean War Navy Technicians: Mortality Survey after 40 Years

814

Cancer in Lebanon: An Epidemiological Review of the American University of Beirut Medical Center Tumor Registry (1983–1994)

815

Cancer in married couples: Higher or lower distress?

816

Cancer in Maysan: Mortality, Pattern, and Demographic Characteristics during the Last 4 Decades

817

Cancer in patients on dialysis for end-stage renal disease: an international collaborative study Original Research Article

818

Cancer in patients on renal replacement therapy in Lombardy, Italy

819

Cancer in people with depression or anxiety: record-linkage study

820

Cancer in pregnancy: Gaps, challenges and solutions

821

Cancer in siblings of children with cancer in the Nordic countries: a population-based cohort study

822

Cancer in the mass print media: Fear, uncertainty and the medical model

823

Cancer in the older person

824

Cancer in the Sudan: An overview of the current status of knowledge on tumor patterns and risk factors Original Research Article

825

Cancer incidence among Danish Seventh-day Adventists and Baptists

826

Cancer incidence among Mormons and non-Mormons in Utah (United States) 1995–1999

827

Cancer incidence among pesticide applicators exposed to trifluralin in the Agricultural Health Study

828

Cancer incidence among refinery and petrochemical employees in Louisiana, 1983–1999

829

Cancer Incidence among the Elderly Population in the Northwest of Iran: A Population Based Study

830

Cancer incidence and asbestos in drinking water, Town of Woodstock, New York, 1980–1998

831

Cancer incidence and mortality after radioiodine treatment for hyperthyroidism

832

Cancer incidence and mortality after radioiodine treatment for hyperthyroidism

833

Cancer incidence and mortality after radioiodine treatment for hyperthyroidism: a population-based cohort study

834

Cancer Incidence and Mortality in Ardabil: Report of an Ongoing Population-Based Cancer Registry in Iran, 2004-2006

835

Cancer incidence and mortality in people aged less than 75 years: Changes in Australia over the period 1987–2007

836

Cancer Incidence and Prevalence in Isfahan: Application of Mortality Data to Estimates and Projects for the Period 2001-2015

837

Cancer Incidence and Trend Analysis in Shahroud, Iran, 2000 – 2010

838

Cancer Incidence around an Oil Refinery as an Example of a Small Area Study Based on Map Coordinates

839

Cancer incidence estimation at a district level without a national registry: A validation study for 24 cancer sites using French health insurance and registry data

840

Cancer incidence in a petrochemical industry area in Sweden Original Research Article

841

Cancer incidence in children conceived with assisted reproduction technology

842

Cancer incidence in Dutch Balkan veterans

843

Cancer incidence in ethnic German migrants from the Former Soviet Union in comparison to the host population

844

Cancer Incidence in Golestan Province: Report of an Ongoing Population-based Cancer Registry in Iran between 2004 and 2008

845

Cancer incidence in Jordan, 1996–2005

846

Cancer Incidence in Montana: Rates for American Indians Exceed Those for Whites Original Research Article

847

Cancer incidence in people with hepatitis B or C infection: A large community-based linkage study

848

Cancer incidence in postwar Lebanon: findings from the first national population-based registry, 1998

849

Cancer Incidence in South East of Iran: Results of a Population-Based Cancer Registry

850

Cancer Incidence in Tehran Metropolis: The First Report from the Tehran Population-Based Cancer Registry, 1998 – 2001

851

Cancer incidence in the USA could double by 2050, report predicts

852

Cancer incidence in women exposed to DES in utero

853

Cancer Incidence Rate in the Elderly Inhabitants of Tehran: Is there Really any Cluster?

854

Cancer incidence rate ratios of Turkish immigrants in Hamburg, Germany: A registry based study

855

Cancer Incidence Rates among Iranian immigrants in Sweden, a Population-Based Retrospective Cohort Study

856

Cancer Incidence, Mortality and Survival in Türkiye as of 2020

857

Cancer indifférencié du cavum type : états des lieux dans le service de radiothérapie du centre hospitalier universitaire d’Oran

858

Cancer indifférencié du cavum type : états des lieux dans le service de radiothérapie du centre hospitalier universitaire d’Oran

859

Cancer indifférencié du cavum : aspects épidémiologiques, cliniques et thérapeutiques

860

Cancer indifférencié du cavum : aspects épidémiologiques, cliniques et thérapeutiques

861

Cancer Induced Infertility and the Role of L-Carnitine: A Review for Possible Future Clinical Applications

862

Cancer informatics by prototype networks in mass spectrometry

863

Cancer Information Service-Initiated Outcalls to Promote Screening Mammography among Low-Income and Minority Women: Design and Feasibility Testing, ,

864

Cancer initiation by fumonisin B1 in rat liver – role of cell proliferation

865

Cancer Invasion and the Microenvironment: Plasticity and Reciprocity

866

Cancer Is to Embryology as Mutation Is to Genetics: Hypothesis of the Cancer as Embryological Phenomenon

867

Cancer letters special issue hepatocellular carcinoma featuring the guest editors

868

Cancer Letters special issue inflammation and gastrointestinal and liver cancers featuring the guest editor

869

Cancer Letters. Featuring the guest editors: Wael M. ElShamy and Roy J. Duhé

870

Cancer magnitude, challenges and control in the Eastern Mediterranean Region

871

Cancer marker detection in human serum with a point-of-care low-cost system

872

Cancer metabolism and the dynamics of metastasis

873

Cancer Metabolism and Tumor Heterogeneity: Imaging Perspectives Using MR Imaging and Spectroscopy

874

Cancer Metabolism: Is Glutamine Sweeter than Glucose?

875

Cancer metastasis at a glance: A brief view of Breast Cancer Brain Metastasis

876

Cancer Metastasis Is Accelerated through Immunosuppression during Snail-Induced EMT of Cancer Cells

877

Cancer mode of action, weight of evidence, and proposed cancer reference value for hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX)

878

Cancer Modeling and Simulation, L. Preziosi (Ed.). Chapman and Hall/CRC (2003)

879

Cancer Modeling in the Modern Era: Progress and Challenges

880

Cancer Molecular Analysis Project: Weaving a rich cancer research tapestry

881

Cancer molecules reveal their mechanisms

882

Cancer morbidity in subjects occupationally exposed to high frequency (radiofrequency and microwave) electromagnetic radiation

883

Cancer mortality among agricultural workers from Serrana Region, state of Rio de Janeiro, Brazil

884

Cancer mortality among workers in formaldehyde industries

885

Cancer mortality among workers in the meat department of supermarkets : E. S. Johnson, Occupational and Environmental Medicine, 51(8), 541–547

886

Cancer mortality and occupational exposure to aromatic amines and inhalable aerosols in rubber tire manufacturing in Poland

887

Cancer mortality and offset printing

888

Cancer mortality and prevention in the European Union

889

Cancer mortality around French nuclear sites

890

Cancer mortality in Basrah: a household survey results

891

Cancer nanomedicine: A review on approaches and applications towards targeted drug delivery

892

Cancer nanomedicines targeting tumor extracellular pH

893

Cancer nanomedicines: So many papers and so few drugs!

894

Cancer nanotechnology

895

Cancer nanotechnology

896

Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology

897

Cancer Nursing: Care in Context: Jessica Corner, Christopher Bailey (Eds.); Blackwell Science, Oxford, 2001, ISBN 0-632-03998-1

898

Cancer Occurrence in Fars Province, Southern Iran

899

Cancer Occurrence in the Elderly: Agreement between Three Major Data Sources

900

Cancer of children in Basrah-Iraq: Person and time characteristics

901

Cancer of Male Urethra: Case Series and Review of Literature

902

Cancer of the breast, fifth edition.: William L. Donegan and John S. Spratt publisher: Saunders, Philadelphia, pages: 1,025. price: $179.00

903

Cancer of the breast: Is radiation therapy curative

904

Cancer of the Colon and Rectum in California: Trends in Incidence by Race/Ethnicity, Stage, and Subsite,

905

Cancer of the esophagus: histopathological sub-types in northern Uganda

906

Cancer of the gastric cardia

907

Cancer of the gastrointestinal tract results in a restricted T-cell repertoire dependent upon tumor differentiation

908

Cancer of the larynx in females

909

Cancer of the larynx in Hong Kong: a clinico-pathological study

910

Cancer of the pharynx and larynx

911

Cancer of the rectum—palliative endoscopic treatment

912

Cancer of unknown primary origin: a decade of experience in a community-based hospital

913

Cancer of unknown primary patients with midline nodal distribution: Midway between poor and favourable prognosis?

914

Cancer omics: From regulatory networks to clinical outcomes

915

Cancer onset and progression: A genome-wide, nonlinear dynamical systems perspective on onconetworks

916

Cancer pain relief achieved in mice with proenkephalin-expressing herpes vector

917

Cancer pain relief, 2nd Edn : WHO, Geneva. £11.90, ISBN 92 4 154482 1

918

Cancer Pain; Physical Factors affecting Pain Experience

919

Cancer paper retracted

920

Cancer patient advocacy: New opportunities for treatment advances

921

Cancer patient survival in Estonia 1995–2009: Time trends and data quality

922

Cancer patients and loneliness: A systematic review

923

Cancer patients desire for information: a study in a teaching hospita l in Saudi Arabia

924

Cancer patients overestimate survival chances

925

Cancer patients' satisfaction with communication and information given by nurses at teaching hospitals of Tehran, Iran

926

Cancer patientsʹ satisfaction with physicians: Princess Margaret hospital satisfaction with doctor questionnaire results

927

Cancer Patients Who Elect Euthanasia as an Option: An Argumentative Essay

928

Cancer Patients’ Challenges During COVID-19 Pandemic: An Approach to Decision-Making in Management and Policy-Making i

929

Cancer Patients’ Perceptions of Family Psychological Support: A Qualitative Study

930

Cancer Patients’ Perceptions of Family Psychological Support: A Qualitative Study

931

Cancer patients’ reluctance to discuss psychological distress with their physicians was not associated with underrecognition of depression by physicians: A preliminary study

932

Cancer pattern and survival in a rural district in South India

933

Cancer prevention

934

Cancer Prevention - Behavior Changes: The Short and the Long of It

935

Cancer prevention – the potential for diet to modulate molecular signalling

936

Cancer Prevention & Control Strategy: Resolution adopted by the 58th World Health Assembly, Geneva, May 25, 2005

937

Cancer Prevention Among Urban Southwestern American Indian Women: Comparison to Selected Year 2000 National Health Objectives

938

Cancer prevention by carotenoids

939

Cancer prevention by food factors through targeting signal transduction pathways,

940

Cancer Prevention by Protease Inhibitors

941

Cancer prevention by tocopherols and tea polyphenols

942

Cancer prevention in primary care: Predictors of patient counseling across four risk behaviors over 24 months

943

Cancer prevention in rural primary care: An academic-practice partnership

944

Cancer prevention studies: Past, present, and future directions

945

Cancer prevention studies—Past, present, and future directions

946

Cancer prevention trials and primary care physicians: Factors associated with recommending trial enrollment

947

Cancer Prevention: Chemoprevention vs Dietary Modifications

948

Cancer prevention: epidemiology and experiment

949

Cancer Prevention; Cancer Risk Management

950

Cancer Prevention; Emerging Infectious Diseases as Risk Factors, Iran Feature

951

Cancer preventive agents, Part 2: Synthesis and evaluation of 2-phenyl-4-quinolone and 9-oxo-9,10-dihydroacridine derivatives as novel antitumor promoters Original Research Article

952

Cancer preventive agents. Part 1: Chemopreventive potential of cimigenol, cimigenol-3,15-dione, and related compounds Original Research Article

953

Cancer preventive effects of flavonoids—a review

954

Cancer preventive potential of trichothecenes from Trichothecium roseum Original Research Article

955

Cancer preventive properties of ginger: A brief review

956

Cancer preventive screening: A cross-border comparison of United States and Canadian Chinese women

957

Cancer procoagulant and blood platelet activation

958

Cancer progression and p53

959

Cancer progression is associated with increased expression of basement membrane proteins in three-dimensional in vitro models of human oral cancer

960

Cancer prostatique localisé traité par irradiation conformationnelle avec modulation dʹintensité avec ou sans repositionnement échographique : la dose reçue est-elle équivalente à la dose prescrite ?

961

Cancer prostatique localisé traité par irradiation conformationnelle avec modulation dʹintensité avec ou sans repositionnement échographique : la dose reçue est-elle équivalente à la dose prescrite ?

962

Cancer proteomics: from signaling networks to tumor markers

963

Cancer proteomics: from signaling networks to tumor markers

964

Cancer radio induit par la radiothérapie des carcinomes nasopharyngés : à propos de huit cas

965

Cancer radio induit par la radiothérapie des carcinomes nasopharyngés : à propos de huit cas

966

Cancer rectocolique chez le sujet jeune

967

Cancer rectocolique chez le sujet jeune

968

Cancer Registry in Iran: a Brief Overview

969

Cancer related factors do not explain the quality of life scores for childhood cancer survivors analysed with two different generic HRQL instruments

970

Cancer Related Fears in Iranian Patients, a Survey from South East of Iran

971

Cancer related inflammation: The macrophage connection

972

Cancer research priorities for early diagnosis in Iran: Analyses based on Multiple-Attribute Decision Making Model

973

Cancer Research Studies in Native Hawaiians and Pacific Islanders

974

Cancer Research UK looks to NCI forsuccess

975

Cancer researchers get down to arrays at AACR

976

Cancer Resection on the Residual Lung After Pneumonectomy for Bronchogenic Carcinoma

977

Cancer responds better to combined treatments

978

Cancer risk above 1 Gy and the impact for space radiation protection Original Research Article

979

Cancer risk after a hospital discharge diagnosis of endometriosis, , ,

980

Cancer risk after non-melanoma skin cancer

981

Cancer risk among patients with multiple sclerosis: A cohort study in Isfahan, Iran

982

Cancer risk analysis by fuzzy logic approach and performance status of the model

983

Cancer Risk Analysis of Benzene and Ethyl Benzene in Painters

984

Cancer risk and all-cause mortality among Norwegian military United Nations peacekeepers deployed to Kosovo between 1999 and 2011

985

Cancer risk and Barrett’s esophagus

986

Cancer Risk Assessment and the Genetic Counseling Process: Using Hereditary Breast and Ovarian Cancer as an Example

987

Cancer Risk Assessment Benzene, Toluene, Ethylbenzene and Xylene (BTEX) in the Production of Insulation Bituminous

988

Cancer Risk Assessment due to Accidental Exposure inside Neutron Laboratories using BEIR VII Model

989

Cancer risk assessment for Tehran research reactor and radioisotope laboratory with CAP88-PC code (Gaussian plume model)

990

Cancer Risk Assessment for Workers Exposed to Pollution Source, a Petrochemical Company, Iran

991

Cancer Risk Assessment From Multi-Exposure to Chloroform in Drinking Water of Ilam City, Iran

992

Cancer risk assessment from trihalomethanes in drinking water

993

Cancer Risk Assessment in Welder's Under Different Exposure Scenarios

994

Cancer risk assessment using blood dioxin levels and daily dietary TEQ intake in general populations of industrial and non-industrial countries

995

Cancer Risk Assessment: Evolution of the Process

996

Cancer Risk Assessment: Quality and Impact of the Family History Interview

997

Cancer Risk at Sites Other than the Breast Following Augmentation Mammoplasty

998

Cancer risk due to contamination: Consideration from market basket survey in Qatar

999

Cancer risk factors among men of diverse Hispanic or Latino origins

1000

Cancer risk in endoscopically unresectable colon polyps